Código QR (código de barras bidimensional)

Dupilumab in patients with bullous pemphigoid and concomitant atopy

BackgroundBullous pemphigoid (BP) and atopic dermatitis (AD) are chronic inflammatory skin diseases that may share overlapping immunopathogenic mechanisms, particularly a type 2 immune response. Emerging evidence suggests that dupilumab, an IL-4Rα antagonist, may be effective in treating both condit...

Fuld beskrivelse

Na minha lista:
Principais autores: Katerina Jobst, Stephan R. Künzel, Stefan Beissert, Susanne Abraham
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2025-08-01
Serier:Frontiers in Pharmacology
Fag:
bullous pemphigoid
atopic dermatitis
dupilumab
tralokinumab
Anti-IL4/13 antibody
targeted therapy
Online adgang:https://www.frontiersin.org/articles/10.3389/fphar.2025.1656089/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker